Compounds > dermatan sulfate
Page last updated: 2024-08-23

dermatan sulfate and Multiple Organ Failure

dermatan sulfate has been researched along with Multiple Organ Failure in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's5 (83.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Iba, T; Miyasho, T1
Biesma, DH; Haas, FJ; Leusink, JA; Veth, G; Wester, JP1
Hassell, K1
Fukunaga, M; Iba, T; Ida, Y; Kidokoro, A; Nagakari, K; Suda, M; Yoshikawa, S1
Bauersachs, R; Betz, C; Lindhoff-Last, E1
John, G; Mudaliar, Y; Shehabi, Y1

Reviews

1 review(s) available for dermatan sulfate and Multiple Organ Failure

ArticleYear
The management of patients with heparin-induced thrombocytopenia who require anticoagulant therapy.
    Chest, 2005, Volume: 127, Issue:2 Suppl

    Topics: Angina, Unstable; Antibodies; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Female; Fondaparinux; Heparin; Heparitin Sulfate; Hirudins; Humans; Male; Multiple Organ Failure; Platelet Factor 4; Polysaccharides; Pregnancy; Preoperative Care; Recombinant Proteins; Thrombin; Thrombocytopenia; Venous Thrombosis

2005

Other Studies

5 other study(ies) available for dermatan sulfate and Multiple Organ Failure

ArticleYear
Danaparoid sodium attenuates the increase in inflammatory cytokines and preserves organ function in endotoxemic rats.
    Critical care (London, England), 2008, Volume: 12, Issue:4

    Topics: Animals; Chondroitin Sulfates; Cytokines; Dermatan Sulfate; Endotoxemia; Heparitin Sulfate; Inflammation Mediators; Lipopolysaccharides; Multiple Organ Failure; Rats; Rats, Wistar

2008
Thrombosis and hemorrhage in heparin-induced thrombocytopenia in seriously ill patients.
    Intensive care medicine, 2004, Volume: 30, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Case-Control Studies; Chondroitin Sulfates; Critical Illness; Dermatan Sulfate; Drug Combinations; Female; Hemorrhage; Heparin; Heparitin Sulfate; Humans; Incidence; Intensive Care Units; Male; Middle Aged; Multiple Organ Failure; Risk Factors; Thrombocytopenia; Venous Thrombosis

2004
Antithrombin ameliorates endotoxin-induced organ dysfunction more efficiently when combined with danaparoid sodium than with unfractionated heparin.
    Intensive care medicine, 2005, Volume: 31, Issue:8

    Topics: 6-Ketoprostaglandin F1 alpha; Alanine Transaminase; Animals; Anticoagulants; Antithrombins; Blood Urea Nitrogen; Chondroitin Sulfates; Dermatan Sulfate; Drug Therapy, Combination; Fibrinolytic Agents; Heparin; Heparitin Sulfate; Interleukin-6; Leukocyte Count; Lipopolysaccharides; Multiple Organ Failure; Platelet Count; Rats; Rats, Wistar

2005
Use of a low-molecular-weight heparinoid (danaparoid sodium) for continuous renal replacement therapy in intensive care patients.
    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2001, Volume: 7, Issue:4

    Topics: Adult; Aged; Anticoagulants; Chondroitin Sulfates; Contraindications; Critical Care; Dermatan Sulfate; Drug Combinations; Drug Evaluation; Female; Hemorrhage; Heparin; Heparinoids; Heparitin Sulfate; Humans; Male; Middle Aged; Multiple Organ Failure; Renal Replacement Therapy; Retrospective Studies; Thrombosis; Treatment Outcome

2001
Use of a low molecular weight preparation of heparin--ORG 10172 (Lomoparan) in the critically ill.
    Anaesthesia and intensive care, 1991, Volume: 19, Issue:4

    Topics: Chondroitin Sulfates; Critical Illness; Dermatan Sulfate; Extracorporeal Circulation; Female; Glycosaminoglycans; Hemofiltration; Heparinoids; Heparitin Sulfate; Humans; Male; Middle Aged; Multiple Organ Failure; Renal Dialysis; Thrombocytopenia

1991